- Hans-Joachim Anders, Ludwig-Maximilians-University
- Adrian Covic, Parhon University Hospital
- Michelle Estrella, Johns Hopkins School of Medicine
- Bernard Jaar, Johns Hopkins Medical Institutions
- William Oetting, University of Minnesota
- Giorgina Piccoli, University of Torino
- Donald S Silverberg, Tel Aviv Medical Center
- Robert Unwin, University College London
- Hayley Henderson, BioMed Central
Intermittent oral alfacalcidol administration during haemodialysis sessions is more effective than the equivalent IV dosage with a greater efficacy to reduce serum parathormone, presenting a more cost-efficient strategy over IV administration.
A combination of three different advanced electron microscopic techniques have helped to determine the structural basis of two additional layers of the Glomerular Filtration Barrier (GFB), which should allow identification of structural features regulating physiology, serving to better understand kidney disease.
Serum cystatin C (ScysC) performs significantly better than serum creatinine (SCr) for the detection of an impaired GFR in critically ill patients and may be a more valid GFR biomarker than SCr.
Tanya Johns and Bernard Jaar discuss a new CKD surveillance website, launched by the Centers for Disease Control and Prevention, which aims to promote public health strategies and awareness, leading to early detection and prevention of CKD and ultimately reducing the burden of this disease in the US.
David Gustafsson and Robert Unwin look into uric acid metabolism and review the current literature on the pathophysiology of hyperuricaemia, discussing its possible relationship to cardiovascular disease, morbidity and mortality and emerging treatment options.BMC Nephrology 2013, 14:164
BMC Nephrology 2014, 15:44
BMC Nephrology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Nephrology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at firstname.lastname@example.org, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
BMC series blog
- 04 March 2014
- Highlights of the BMC-series: February 2014
- 03 March 2014
- Hiding the truth – how one bird fools another
News from the web
Section Editor's profile
William Oetting is currently a Professor in the Departments of Experimental and Clinical Pharmacology in the College of Pharmacy and Genetics, Cell Biology and Development at in the MedicalSchool at the University of Minnesota. Professor Oetting's research focuses on the genetic analysis of common diseases. In particular, the effects of genetic variation on kidney allograft health and survival for kidney transplant recipients. As genetic variants associated with kidney function and/or disease are identified, they will become candidates for other diseases which include the kidney. He is also interested in identifying proteomic and metabolomics markers associated with kidney health after transplantation.
"I am pleased to have been involved with BMC Nephrology, first as an Associate Editor and now as Section Editor for the Genetics section. I have been impressed with the journal's high editorial standards, and rapidity of the peer review and publication process. Moreover, I strongly believe in the value of BMC Nephrology's open access policy, which makes new knowledge available to the global nephrology community, irrespective of institutional affiliation or financial means.
The genetics section of BMC Nephrology will provide a forum for investigators who are interested in genetic variation and their impact on kidney development, function, disease and response to therapy. Kidney disease is the ninth leading cause of death in the United States. The variability between individuals with kidney disease on overall health (e.g. glomerular diseases), or on kidney health (e.g. type 2 diabetes), shows why understanding the genetics of kidney disease is important. I am looking forward to the many contributions associated with the genetics of kidney health and disease that will be published in BMC Nephrology."